A Night to Remember Downtown

L-R: Oren Heiman, Shaya Boymelgreen, Michael Shvo

American Friends of Rabin Medical Center and the New Circle Committee members hosted a fun-filled evening for Israeli professionals in real estate and finance on March 23, 2006 at the prestigious new 20 Pine Street building, referred to as "The Collection." The building itself, where this event was held, was itself an example of the Israeli influence on American real estate because it was a project that converted a bank into residential condominiums and was designed by Armani Casa, developed by Leviev-Boymelgreen, and marketed by Shvo Concepts. Leading Israeli developers, including Shaya Boymelgreen, greeted the guests while Ofer Yardeni and Moshe Azogui mixed with the participants. Over 400 people attended the event, which will be the first of several programs established by the New Circle of American Friends of Rabin Medical Center. Oren Heiman and Michael Shvo made presentations on the success of Israeli real estate and finance in the United States in 2005 and speculated on the future for Israel in this industry. The atmosphere was congenial and informative, with the presence of an open bar, a light dinner, and Israeli music playing in the background.

Related Articles

The Art of Healing: Art by Breast Cancer Survivors


Everyone is aware of the level of expert care that Rabin Medical Center offers to its patients. What is less well known, however, is the degree of thought that goes into planning and managing a patient's care.


read more »

New Radiation Treatment Offers Hope for Lung Tumors


For the first time in Israel, at Rabin Medical Center Stereotactic Body Radiation (SBRT) treatment is available for certain lung cancer patients using the Trilogy Linear Accelerator, the most advanced accelerator available today.


read more »

Rabin Medical Center Saves Breast Cancer Patients with New Mammography Techniques


A researcher at Zebra Medical Vision has created a new mammography algorithm that uses machine and deep learning to diagnose breast cancer (BC), with results that the company claims are superior to those achieved using current methods.


read more »